+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

North America Cell Viability Assays Market Size, Share & Industry Trends Analysis Report By Product, By End User, By Application (Stem Cell Research, Drug Discovery & Development, and Diagnostics), By Country and Growth Forecast, 2022 - 2028

  • PDF Icon

    Report

  • 108 Pages
  • December 2022
  • Region: North America
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 5723817
The North America Cell Viability Assays Market should witness market growth of 8.5% CAGR during the forecast period (2022-2028).

It is recommended to understand the quantity of the remaining viable cells after the experiment, regardless of the type of cell-based assay employed. Various assay methods can determine the number of viable eukaryotic cells. Some of them are resazurin reduction, protease markers, ATP detection, and tetrazolium reduction.

The tetrazolium reduction, protease activity assays, and resazurin reduction assays measure some aspect of the enzymatic activity or general metabolism as a viable cells’ marker. To transform a substrate into a fluorescent or colored product that is detectable with the help of a plate reader, all of these assays require incubating a reagent with the viable cell population. A signal in proportion to the quantity of the present viable cells will be created when the substrates are set with the viable cells under most standard cultural conditions.

Most of the medical decisions rely on laboratory test results, which showcase the crucial role of clinical laboratories in the present healthcare system. According to Center of Centers for Disease Control and Preventions, annually, approximately 14 billion laboratory tests are ordered, and for an effective diagnosis and treatment of disease, quality, cost-effectiveness, and safe laboratory testing are required.

The US market dominated the North America Cell Viability Assays Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $634.6 million by 2028. The Canada market is poised to grow at a CAGR of 10.9% during (2022-2028). Additionally, The Mexico market should witness a CAGR of 9.9% during (2022-2028).

Based on Product, the market is segmented into Consumables (Reagents & Assay Kits and Microplates) and Instruments (Spectrophotometer, Microscopy, Cell Imaging & Analysis System, Flow Cytometry, and Others). Based on Reagents & Assay Kits, the market is segmented into Luminometric Assays, Dye Exclusion Assays, Colorimetric Assays, and Fluorometric Assays. Based on End-user, the market is segmented into Biopharmaceutical & Pharmaceutical Companies, CROs & CMOs, Academic & Research Institutes, and Diagnostic Labs. Based on Application, the market is segmented into Stem Cell Research, Drug Discovery & Development, and Diagnostics. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Thermo Fisher Scientific Inc., Agilent Technologies, Inc., Bio-Rad Laboratories Inc., Merck KGaA, Becton, Dickinson and Company, PerkinElmer Inc., Promega Corporation, Biotium, Creative Bioarray, and Abcam Plc.

Scope of the Study

By Product

  • Consumables
    • Reagents & Assay Kits
      • Luminometric Assays
      • Dye Exclusion Assays
      • Colorimetric Assays
      • Fluorometric Assays
    • Microplates
  • Instruments
    • Spectrophotometer
    • Microscopy
    • Cell Imaging & Analysis System
    • Flow Cytometry
    • Others

By End-user

  • Biopharmaceutical & Pharmaceutical Companies
  • CROs & CMOs
  • Academic & Research Institutes
  • Diagnostic Labs

By Application

  • Stem Cell Research
  • Drug Discovery & Development
  • Diagnostics

By Country

  • US
  • Canada
  • Mexico
  • Rest of North America

Key Market Players

List of Companies Profiled in the Report:

  • Thermo Fisher Scientific Inc.
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories Inc.
  • Merck KGaA
  • Becton, Dickinson and Company
  • PerkinElmer Inc.
  • Promega Corporation
  • Biotium
  • Creative Bioarray
  • Abcam Plc

Unique Offerings

  • Exhaustive coverage
  • The highest number of market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Cell Viability Assays Market, by Product
1.4.2 North America Cell Viability Assays Market, by End User
1.4.3 North America Cell Viability Assays Market, by Application
1.4.4 North America Cell Viability Assays Market, by Country
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market composition and Scenarios
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Competition Analysis - Global
3.1 Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)

Chapter 4. North America Cell Viability Assays Market by Product
4.1 North America Consumables Market by Country
4.2 North America Cell Viability Assays Market by Consumables Type
4.2.1 North America Reagents & Assay Kits Market by Country
4.2.2 North America Cell Viability Assays Market by Reagents & Assay Kits Type
4.2.2.1 North America Luminometric Assays Market by Country
4.2.2.2 North America Dye Exclusion Assays Market by Country
4.2.2.3 North America Colorimetric Assays Market by Country
4.2.2.4 North America Fluorometric Assays Market by Country
4.2.3 North America Microplates Market by Country
4.3 North America Instruments Market by Country
4.4 North America Cell Viability Assays Market by Instruments Type
4.4.1 North America Spectrophotometer Market by Country
4.4.2 North America Microscopy Market by Country
4.4.3 North America Cell Imaging & Analysis System Market by Country
4.4.4 North America Flow Cytometry Market by Country
4.4.5 North America Others Market by Country

Chapter 5. North America Cell Viability Assays Market by End-user
5.1 North America Biopharmaceutical & Pharmaceutical Companies Market by Country
5.2 North America CROs & CMOs Market by Country
5.3 North America Academic & Research Institutes Market by Country
5.4 North America Diagnostic Labs Market by Country

Chapter 6. North America Cell Viability Assays Market by Application
6.1 North America Stem Cell Research Market by Country
6.2 North America Drug Discovery & Development Market by Country
6.3 North America Diagnostics Market by Country

Chapter 7. North America Cell Viability Assays Market by Country
7.1 US Cell Viability Assays Market
7.1.1 US Cell Viability Assays Market by Product
7.1.1.1 US Cell Viability Assays Market by Consumables Type
7.1.1.1.1 US Cell Viability Assays Market by Reagents & Assay Kits Type
7.1.1.2 US Cell Viability Assays Market by Instruments Type
7.1.2 US Cell Viability Assays Market by End-user
7.1.3 US Cell Viability Assays Market by Application
7.2 Canada Cell Viability Assays Market
7.2.1 Canada Cell Viability Assays Market by Product
7.2.1.1 Canada Cell Viability Assays Market by Consumables Type
7.2.1.1.1 Canada Cell Viability Assays Market by Reagents & Assay Kits Type
7.2.1.2 Canada Cell Viability Assays Market by Instruments Type
7.2.2 Canada Cell Viability Assays Market by End-user
7.2.3 Canada Cell Viability Assays Market by Application
7.3 Mexico Cell Viability Assays Market
7.3.1 Mexico Cell Viability Assays Market by Product
7.3.1.1 Mexico Cell Viability Assays Market by Consumables Type
7.3.1.1.1 Mexico Cell Viability Assays Market by Reagents & Assay Kits Type
7.3.1.2 Mexico Cell Viability Assays Market by Instruments Type
7.3.2 Mexico Cell Viability Assays Market by End-user
7.3.3 Mexico Cell Viability Assays Market by Application
7.4 Rest of North America Cell Viability Assays Market
7.4.1 Rest of North America Cell Viability Assays Market by Product
7.4.1.1 Rest of North America Cell Viability Assays Market by Consumables Type
7.4.1.1.1 Rest of North America Cell Viability Assays Market by Reagents & Assay Kits Type
7.4.1.2 Rest of North America Cell Viability Assays Market by Instruments Type
7.4.2 Rest of North America Cell Viability Assays Market by End-user
7.4.3 Rest of North America Cell Viability Assays Market by Application

Chapter 8. Company Profiles
8.1 Thermo Fisher Scientific, Inc.
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.1.5 Recent strategies and developments:
8.1.5.1 Partnerships, Collaborations, and Agreements:
8.1.5.2 Product Launches and Product Expansions:
8.1.5.3 Acquisition and Mergers:
8.1.5.4 Geographical Expansions:
8.2 Agilent Technologies, Inc.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.3 Bio-Rad laboratories, Inc.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expenses
8.3.5 Recent strategies and developments:
8.3.5.1 Partnerships, Collaborations, and Agreements:
8.3.5.2 Acquisition and Mergers:
8.4 Becton, Dickinson and Company
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expense
8.4.5 Recent strategies and developments:
8.4.5.1 Product Launches and Product Expansions:
8.4.5.2 Acquisition and Mergers:
8.5 PerkinElmer, Inc.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expense
8.5.5 Recent strategies and developments:
8.5.5.1 Product Launches and Product Expansions:
8.5.5.2 Acquisition and Mergers:
8.6 Merck KGaA
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expense
8.7 Abcam plc
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expenses
8.8 Promega Corporation
8.8.1 Company Overview
8.8.2 Recent strategies and developments:
8.8.2.1 Partnerships, Collaborations, and Agreements:
8.8.2.2 Product Launches and Product Expansions:
8.9 Creative Bioarray
8.9.1 Company Overview
8.10. Biotium, Inc.
8.10.1 Company Overview

Companies Mentioned

  • Thermo Fisher Scientific Inc.
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories Inc.
  • Merck KGaA
  • Becton, Dickinson and Company
  • PerkinElmer Inc.
  • Promega Corporation
  • Biotium
  • Creative Bioarray
  • Abcam Plc

Methodology

Loading
LOADING...